Targeted ATG Dosing Pilot Study

Matched Unrelated Donor and Partially Matched Related Donor Peripheral Stem Cell Transplantation With Alpha/Beta T-Cell and B-Cell Depletion for Patients With Hematologic Malignancies With Targeted ATG Dosing Pilot Study, IDE 13641

More Information

Trial Status
Accepting patients
Trial Phase
Phase 0
Enrollment
40 patients (estimated)
Sponsors
Medical College of Wisconsin
Tags
Allogeneic Stem Cell Transplant
Trial Type
Treatment
Last Update
10 months ago
SparkCures ID
1867
NCT Identifier
NCT05794880

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.